Recruiting PHASE2 INTERVENTIONAL 4-arm NCT06873516

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

A Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria

Sponsor: Evommune, Inc.

Conditions Chronic Spontaneous Urticaria

Interventions EVO756 Placebo control

Updated 7 times since 2025 Last updated: Jan 19, 2026 Started: Mar 20, 2025 Primary completion: May 31, 2026 Completion: May 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Chronic Spontaneous Urticaria and is currently actively recruiting participants. Evommune, Inc. leads this study, which shows 7 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE2
Nov 2025 — Feb 2026 [monthly]

Recruiting PHASE2
Oct 2025 — Nov 2025 [monthly]

Recruiting PHASE2
Aug 2025 — Oct 2025 [monthly]

Recruiting PHASE2
Jul 2025 — Aug 2025 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

May 2025 — Jul 2025 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Apr 2025 — May 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Mar 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Evommune, Inc.

Data source: Evommune, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Asheville, United States , Austin, United States , Baltimore, United States , Baton Rouge, United States , Birmingham, United States , Boardman, United States , Boston, United States , Canal Winchester, United States , Charlotte, United States , Cincinnati, United States and 42 more locations